License Agreement

Cassiopea will receive an upfront payment of $5 million, in addition to double-digit regulatory and sales milestones as well as…

Once the clinical trials are successfully completed in India, Biosergen and Alkem aim to expand its use for similar patient groups…

The institute has recently obtained permission to initiate the Phase I clinical trials for the drug

CARITEC is an obstetric drug to prevent post-partum hemorrhage

Sosei Heptares to get an upfront payment, research funding and potential near-term development milestones of up to £34 million…

The agreement includes the development candidate ATA3271, an armored allogeneic T-cell immunotherapy, and an autologous version,…

Jounce will lead the development of JTX-1811 through IND clearance, and thereafter, Gilead will have the sole right to develop…

As per the exclusive license agreement, Genor to lead clinical development, regulatory submissions and commercialisation of…

Equillium had originally secured exclusive rights to develop and commercialize Biocon’s novel biologic, itolizumab, for the US and…

Under the terms of the license agreement, CMS will pay Sun Pharma an initial upfront payment, regulatory and sales milestone…